Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Neurodegenerative Disease

PUBLISHER: Grand View Research | PRODUCT CODE: 1609615

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1609615

Deep Brain Stimulation In Parkinson's Disease Market Size, Share & Trends Analysis Report By Product (Single-channel, Dual-channel), By End-use (Hospitals, ASCs), By Region, And Segment Forecasts, 2025 - 2030

PUBLISHED:
PAGES: 100 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 5950
Printable PDF (5-User License)
USD 6950
Printable PDF (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Deep Brain Stimulation In Parkinson's Disease Market Growth & Trends:

The global deep brain stimulation in Parkinson's disease market size is anticipated to reach USD 1.61 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 10.1% from 2025 to 2030. Surge in the incidence of Parkinson's Disease (PD) and growing awareness about the deep brain stimulation in PD are driving the market.

Rising prevalence of Parkinson's disease has raised the demand for deep brain stimulators as an alternative therapy. Deep brain stimulation has been proved to play an important role in providing therapeutic solutions for the symptoms of Parkinson's disease, which is expected to fuel the market growth during the forecast period.

Moreover, increasing demand for minimally invasive therapies due to improved patient outcomes is a high impact rendering driver for this market. This is due to high cost efficiency, minimal pain, safety, short duration of hospital stays, speedy recovery, and few cases of post-surgical problems. These key factors are anticipated to raise the demand for deep brain stimulators over the forecast period.

In addition, technological advancements by the key players for the improved postoperative outcomes and reduced adverse effects in the treatment of PD symptoms are anticipated to raise the demand for deep brain stimulation. For instance, in January 2020, Abbott's Infinity deep brain stimulation system has secured expanded indication approval from the FDA for the treatment of PD. This system will allow to target patients' specific area of the brain called internal globus pallidus (GPi), which is associated with Parkinson's disease symptoms.

Deep Brain Stimulation In Parkinson's Disease Market Report Highlights:

  • The dual channel segment dominated the market with the share of 56.9% in 2024 owing to its increasing adoption by neurosurgeons as it is highly effective in reducing patient tremors
  • On the basis of end-use, hospitals dominated the market in 2024 since deep brain stimulation procedures are the most complicated and critical surgeries that are performed in hospitals due to availability of high quality and durable equipment
  • North America dominated the market with in 2024 owing to prevalence of psychological disorders and presence of well-established healthcare facilities in the region.
Show more
Product Code: GVR-4-68038-749-0

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources & Third-Party Perspectives
    • 1.3.4. Primary Research
  • 1.4. Information Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Data Visualization
  • 1.6. Data Validation & Publishing

Chapter 2. Executive Summary

  • 2.1. Market Insights
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. Deep Brain Stimulation In Parkinson's Disease Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Deep Brain Stimulation In Parkinson's Disease Market: Product Outlook Estimates & Forecasts

  • 4.1. Deep Brain Stimulation In Parkinson's Disease Market: Product Movement Analysis, 2024 & 2030
    • 4.1.1. Single-channel
      • 4.1.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 4.1.2. Dual-channel
      • 4.1.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 5. Deep Brain Stimulation In Parkinson's Disease Market: End Use Outlook Estimates & Forecasts

  • 5.1. Deep Brain Stimulation In Parkinson's Disease Market: End Use Movement Analysis, 2024 & 2030
    • 5.1.1. Hospitals
      • 5.1.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.1.2. Neurology Clinics
      • 5.1.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.1.3. Ambulatory Surgical Centers
      • 5.1.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.1.4. Research Centers
      • 5.1.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 6. Deep Brain Stimulation In Parkinson's Disease Market Regional Outlook Estimates & Forecasts

  • 6.1. Regional Market Share Analysis, 2024 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.4. North America
    • 6.4.1. North America market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. U.S.
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Regulatory framework
      • 6.4.2.3. Competitive insights
      • 6.4.2.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Canada
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. Regulatory framework
      • 6.4.3.3. Competitive insights
      • 6.4.3.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. Mexico
      • 6.4.4.1. Key country dynamics
      • 6.4.4.2. Regulatory framework
      • 6.4.4.3. Competitive insights
      • 6.4.4.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.5. Europe
    • 6.5.1. Europe market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Germany
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework
      • 6.5.2.3. Competitive insights
      • 6.5.2.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. UK
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework
      • 6.5.3.3. Competitive insights
      • 6.5.3.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.4. Italy
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Regulatory framework
      • 6.5.4.3. Competitive insights
      • 6.5.4.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.5. France
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Regulatory framework
      • 6.5.5.3. Competitive insights
      • 6.5.5.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.6. Italy
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Regulatory framework
      • 6.5.6.3. Competitive insights
      • 6.5.6.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.7. Spain
      • 6.5.7.1. Key country dynamics
      • 6.5.7.2. Regulatory framework
      • 6.5.7.3. Competitive insights
      • 6.5.7.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.8. Denmark
      • 6.5.8.1. Key country dynamics
      • 6.5.8.2. Regulatory framework
      • 6.5.8.3. Competitive insights
      • 6.5.8.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.9. Sweden
      • 6.5.9.1. Key country dynamics
      • 6.5.9.2. Regulatory framework
      • 6.5.9.3. Competitive insights
      • 6.5.9.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.10. Norway
      • 6.5.10.1. Key country dynamics
      • 6.5.10.2. Regulatory framework
      • 6.5.10.3. Competitive insights
      • 6.5.10.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. China
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework
      • 6.6.2.3. Competitive insights
      • 6.6.2.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. Japan
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework
      • 6.6.3.3. Competitive insights
      • 6.6.3.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. India
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Regulatory framework
      • 6.6.4.3. Competitive insights
      • 6.6.4.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. Indonesia
      • 6.6.5.1. Key country dynamics
      • 6.6.5.2. Regulatory framework
      • 6.6.5.3. Competitive insights
      • 6.6.5.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.6. South Korea
      • 6.6.6.1. Key country dynamics
      • 6.6.6.2. Regulatory framework
      • 6.6.6.3. Competitive insights
      • 6.6.6.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.7. Thailand
      • 6.6.7.1. Key country dynamics
      • 6.6.7.2. Regulatory framework
      • 6.6.7.3. Competitive insights
      • 6.6.7.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.8. Australia
      • 6.6.8.1. Key country dynamics
      • 6.6.8.2. Regulatory framework
      • 6.6.8.3. Competitive insights
      • 6.6.8.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.9. Philippines
      • 6.6.9.1. Key country dynamics
      • 6.6.9.2. Regulatory framework
      • 6.6.9.3. Competitive insights
      • 6.6.9.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.10. Malaysia
      • 6.6.10.1. Key country dynamics
      • 6.6.10.2. Regulatory framework
      • 6.6.10.3. Competitive insights
      • 6.6.10.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.11. Singapore
      • 6.6.11.1. Key country dynamics
      • 6.6.11.2. Regulatory framework
      • 6.6.11.3. Competitive insights
      • 6.6.11.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.7.2. Brazil
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework
      • 6.7.2.3. Competitive insights
      • 6.7.2.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.7.3. Argentina
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework
      • 6.7.3.3. Competitive insights
      • 6.7.3.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.7.4. Colombia
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework
      • 6.7.4.3. Competitive insights
      • 6.7.4.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.7.5. Chile
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Regulatory framework
      • 6.7.5.3. Competitive insights
      • 6.7.5.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.7.6. Venezuela
      • 6.7.6.1. Key country dynamics
      • 6.7.6.2. Regulatory framework
      • 6.7.6.3. Competitive insights
      • 6.7.6.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.8. Middle East & Africa
    • 6.8.1. MEA market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.8.2. South Africa
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Regulatory framework
      • 6.8.2.3. Competitive insights
      • 6.8.2.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key country dynamics
      • 6.8.3.2. Regulatory framework
      • 6.8.3.3. Competitive insights
      • 6.8.3.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.8.4. UAE
      • 6.8.4.1. Key country dynamics
      • 6.8.4.2. Regulatory framework
      • 6.8.4.3. Competitive insights
      • 6.8.4.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.8.5. Turkey
      • 6.8.5.1. Key country dynamics
      • 6.8.5.2. Regulatory framework
      • 6.8.5.3. Competitive insights
      • 6.8.5.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.8.6. Iran
      • 6.8.6.1. Key country dynamics
      • 6.8.6.2. Regulatory framework
      • 6.8.6.3. Competitive insights
      • 6.8.6.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.8.7. Kuwait
      • 6.8.7.1. Key country dynamics
      • 6.8.7.2. Regulatory framework
      • 6.8.7.3. Competitive insights
      • 6.8.7.4. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Vendor Landscape
    • 7.2.1. Company categorization
    • 7.2.2. List of Key Distributors and Channel Partners
    • 7.2.3. List of Potential Customers/End Users
  • 7.3. Competitive Dynamics
    • 7.3.1. Competitive Benchmarking
    • 7.3.2. Strategy Mapping
    • 7.3.3. Heat Map Analysis
  • 7.4. Company Profiles/Listing
    • 7.4.1. ABBOTT
      • 7.4.1.1. Participant's overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Product benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. Medtronic
      • 7.4.2.1. Participant's overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Product benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. Boston Scientific Corporation
      • 7.4.3.1. Participant's overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Product benchmarking
      • 7.4.3.4. Strategic initiatives
Show more
Product Code: GVR-4-68038-749-0

List of Tables

  • Table 1. List of abbreviations
  • Table 2. Deep brain stimulation in Parkinson's disease market estimates and forecasts, by Product, 2018 - 2030 (USD Million)
  • Table 3. Deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 4. Deep brain stimulation in Parkinson's disease market estimates and forecasts, by region, 2018 - 2030 (USD Million)
  • Table 5. North America deep brain stimulation in Parkinson's disease market estimates and forecasts, by country, 2018 - 2030 (USD Million)
  • Table 6. North America deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 7. North America deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 8. U.S. deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 9. U.S. deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 10. Canada deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 11. Canada deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 12. Mexico deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 13. Mexico deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 14. Europe deep brain stimulation in Parkinson's disease market estimates and forecasts, by country, 2018 - 2030 (USD Million)
  • Table 15. Europe deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 16. Europe deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 17. UK deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 18. UK deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 19. Germany deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 20. Germany deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 21. France deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 22. France deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 23. Italy deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 24. Italy deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 25. Spain deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 26. Spain deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 27. Denmark deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 28. Denmark deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 29. Sweden deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 30. Sweden deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 31. Norway deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 32. Norway deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 33. Asia Pacific deep brain stimulation in Parkinson's disease market estimates and forecasts, by country, 2018 - 2030 (USD Million)
  • Table 34. Asia Pacific deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 35. Asia Pacific deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 36. Japan deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 37. Japan deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 38. China deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 39. China deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 40. India deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 41. India deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 42. Indonesia deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 43. Indonesia deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 44. South Korea deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 45. South Korea deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 46. Thailand deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 47. Thailand deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 48. Australia deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 49. Australia deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 50. Philippines deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 51. Philippines deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 52. Malaysia deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 53. Malaysia deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 54. Singapore deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 55. Singapore deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 56. Latin America deep brain stimulation in Parkinson's disease market estimates and forecasts, by country, 2018 - 2030 (USD Million)
  • Table 57. Latin America deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 58. Latin America deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 59. Brazil deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 60. Brazil deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 61. Argentina deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 62. Argentina deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 63. Colombia deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 64. Colombia deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 65. Chile deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 66. Chile deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 67. Venezuela deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 68. Venezuela deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 69. Middle East & Africa deep brain stimulation in Parkinson's disease market estimates and forecasts, by country, 2018 - 2030 (USD Million)
  • Table 70. Middle East & Africa deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 71. Middle East & Africa deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 72. South Africa deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 73. South Africa deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 74. Saudi Arabia deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 75. Saudi Arabia deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 76. UAE deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 77. UAE deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 78. Turkey deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 79. Turkey deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 80. Iran deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 81. Iran deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 82. Kuwait deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 83. Kuwait deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market segmentation
  • Fig. 2 Information procurement
  • Fig. 3 Data analysis models
  • Fig. 4 Market formulation and validation
  • Fig. 5 Market snapshot
  • Fig. 6 Segmental outlook- Product, and End Use
  • Fig. 7 Competitive outlook
  • Fig. 8 Value chain analysis
  • Fig. 9 Market dynamics
  • Fig. 10 Porter's analysis
  • Fig. 11 PESTEL analysis
  • Fig. 12 Deep brain stimulation In Parkinson's disease market, by product: Key takeaways
  • Fig. 13 Deep brain stimulation In Parkinson's disease market, by product: Market share, 2024 & 2030
  • Fig. 14 Deep brain stimulation In Parkinson's disease market, by end use: Key takeaways
  • Fig. 15 Deep brain stimulation In Parkinson's disease market, by end use: Market share, 2024 & 2030
  • Fig. 16 Deep brain stimulation In Parkinson's disease market, by region: Key takeaways
  • Fig. 17 Deep brain stimulation In Parkinson's disease market, by region: Market share, 2024 & 2030
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!